[20120316. Complications of EMR/ESD (71): Bleeding (35) - warfarin (3) experience at Cedars-Sinai Medical Center]
Los Angeles¿¡ À§Ä¡ÇÑ Cedars-Sinai Medical Center¿¡¼ Withdrawal of warfarin prior to a surgical procedure: time to follow the guidelines?¶ó´Â Èï¹Ì·Î¿î ¹ßÇ¥¸¦ ÇÏ¿´½À´Ï´Ù. ÃÊ·ÏÀ» ¿Å±é´Ï´Ù.
"Over a 12-month period, 14 cases of cardioembolic cerebral infarction occurring during the period of warfarin withdrawal for a medical procedure were observed... Cerebral infarctions developed an average of 5.4 days after the last dose of warfarin (range 3-8)... Each had been on chronic anticoagulation with warfarin for more than 1 year." ¿ÍÆĸ°À» ²÷°í ¾à 5ÀÏ° ³ú°æ»öÀÌ ¹ß»ýÇÏ¿´´Ù´Â Á¡ÀÌ Áß¿äÇÒ °Í °°½À´Ï´Ù. ÀÏÁÖÀÏ µ¿¾È ²÷´Â °üÇàÀº ¹«Ã´ À§ÇèÇÒ ¼ö ÀÖ´Ù°í »ý°¢ÇÕ´Ï´Ù.
"Retrospective analysis suggested that all these cerebral infarctions had been potentially preventable. In each case, either the planned procedure did not require discontinuation of warfarin or, when withdrawal was required, no bridging, parenteral anticoagulation was provided to lessen the risk during the warfarin-free period." ÇÕº´Áõ »ç·Ê¸¦ Àß °ËÅäÇØ º¸¾Ò´õ´Ï °¢±â ¾îµò°¡ ¹®Á¦°¡ ÀÖ¾ú´Ù´Â ÁöÀûÀÔ´Ï´Ù. °¡À̵å¶óÀÎÀ» Àß ÁöÄ×´õ¶ó¸é ¸·À» ¼ö ÀÖ¾ú´Ù´Â °á·ÐÀÔ´Ï´Ù. ±×·¡¼ ³í¹®ÀÇ ºÎÁ¦°¡ 'time to follow the guidelines?'ÀÎ ¸ð¾çÀÔ´Ï´Ù.
±¸Ã¼ÀûÀ¸·Î warfarin adjustment ÈÄ ³»½Ã°æÀ» ÇÏ¿´À» ¶§ stroke risk¸¦ Æò°¡ÇÑ ³í¹®µµ ÀÖ¾ú½À´Ï´Ù (Blacker 2003). Atrial fibrillation ȯÀÚ°¡ ³»½Ã°æÀ» ÇßÀ» ¶§ strokeÀÇ ºóµµ¸¦ ÈÄÇâÀûÀ¸·Î Á¶»çÇÑ °ÍÀÔ´Ï´Ù. 1.06%¿¡¼ stroke°¡ ¿Ô´Ù°í ÇÕ´Ï´Ù. Àú´Â ¸Å¿ì ³ôÀº ¼öÄ¡¶ó°í »ý°¢Çϴµ¥ ÀúÀÚ´Â ÇÑ°¡ÇÏ°Ôµµ strokeÀÇ À§ÇÔÀÌ ³·´Ù("The risk of stroke is low")°í ¸»ÇÏ°í ÀÖ½À´Ï´Ù. ÀÌ·±...
RESULTS: Twelve strokes occurred in 987 patients undergoing 1,137 procedures (1.06%/procedure). The risk ranged from 0.31% for patients with nonvalvular AF undergoing routine procedures to 2.93% for complex patients undergoing endoscopies combined with other procedures or with comorbid illnesses. Patients with stroke were more likely to be complex (7/12 vs 219/975, p = 0.04); to be older than 80 years (6/12 vs 187/975, p = 0.017); to have a history of stroke (7/12 vs 194/975, p = 0.004), hypertension (10/12 vs 508/975, p = 0.04), or hyperlipidemia (9/12 vs 334/975, p = 0.005); or to have a family history of vascular disease (10/12 vs 502/975, p = 0.039).
CONCLUSIONS: The risk of stroke in patients with AF whose anticoagulation is adjusted for endoscopies is low, but almost tenfold higher in patients with complex clinical situations. Age, history of stroke, hypertension, hyperlipidemia, and family history of vascular disease may increase the risk of stroke.
ÀÌ¿Í´Â ¹Ý´ë·Î ¿ÍÆĸ°À» ª°Ô ²÷À¸¸é ("more than 80% of patients had warfarin therapy withheld for 5 days or fewer") thromboembolic risk°¡ ±×¸® ³ôÁö ¾Ê´Ù´Â New Mexice ´ëÇÐÀÇ ¿¬±¸µµ ÀÖ½À´Ï´Ù. ¿©ÇÏÆ° ¹«Ã´ Çò°¥¸®´Â ºÐ¾ßÀÔ´Ï´Ù. °¡À̵å¶óÀÎÀ» ¾ó¸¶³ª Àß ÁöÄ×´À³Ä¿¡ ´Þ¸° °Í °°½À´Ï´Ù.
2) Ç×Ç÷¼ÒÆÇÁ¦ Antiplatelets - ³»½Ã°æ ȤÀº Á¶Á÷°Ë»ç Àü ¾Æ½ºÇǸ°, Ç×Ç÷¼ÒÆÇÁ¦¸¦ ²÷À» °ÍÀΰ¡?
3) »õ·Î¿î Ç×ÀÀ°íÁ¦ New oral anticoagulant (NOAC)
4) Ç×Ç÷¼ÒÆÇÁ¦, Ç×ÀÀ°íÁ¦ Áß´Ü Áöħ (»ï¼º¼¿ïº´¿ø 2011)
© ÀÏ¿ø³»½Ã°æ±³½Ç ¹Ù¸¥³»½Ã°æ¿¬±¸¼Ò ÀÌÁØÇà